skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: The plug-based nanovolume Microcapillary Protein Crystallization System (MPCS)

Journal Article · · Acta Crystallographica. Section D: Biological Crystallography
 [1];  [1];  [2];  [2];  [3];  [4];  [5];  [1]
  1. Accelerated Technologies Center for Gene to 3D Structure (United States)
  2. deCODE biostructures Inc., 7869 NE Day Road West, Bainbridge Island, WA 98110 (United States)
  3. Department of Biochemistry, University of Washington, Seattle, WA 98195 (United States)
  4. Seattle Structural Genomics Center for Infectious Disease (United States)
  5. Emerald BioSystems Inc., 7869 NE Day Road West, Bainbridge Island, WA 98110 (United States)

The Microcapillary Protein Crystallization System (MPCS) is a new protein-crystallization technology used to generate nanolitre-sized crystallization experiments for crystal screening and optimization. Using the MPCS, diffraction-ready crystals were grown in the plastic MPCS CrystalCard and were used to solve the structure of methionine-R-sulfoxide reductase. The Microcapillary Protein Crystallization System (MPCS) embodies a new semi-automated plug-based crystallization technology which enables nanolitre-volume screening of crystallization conditions in a plasticware format that allows crystals to be easily removed for traditional cryoprotection and X-ray diffraction data collection. Protein crystals grown in these plastic devices can be directly subjected to in situ X-ray diffraction studies. The MPCS integrates the formulation of crystallization cocktails with the preparation of the crystallization experiments. Within microfluidic Teflon tubing or the microfluidic circuitry of a plastic CrystalCard, ∼10–20 nl volume droplets are generated, each representing a microbatch-style crystallization experiment with a different chemical composition. The entire protein sample is utilized in crystallization experiments. Sparse-matrix screening and chemical gradient screening can be combined in one comprehensive ‘hybrid’ crystallization trial. The technology lends itself well to optimization by high-granularity gradient screening using optimization reagents such as precipitation agents, ligands or cryoprotectants.

OSTI ID:
22347989
Journal Information:
Acta Crystallographica. Section D: Biological Crystallography, Vol. 64, Issue Pt 11; Other Information: PMCID: PMC2585160; PUBLISHER-ID: bw5254; PMID: 19020349; OAI: oai:pubmedcentral.nih.gov:2585160; Copyright (c) Gerdts et al. 2008; This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.; Country of input: International Atomic Energy Agency (IAEA); ISSN 0907-4449
Country of Publication:
Denmark
Language:
English